JP2014505655A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505655A5
JP2014505655A5 JP2013530433A JP2013530433A JP2014505655A5 JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5 JP 2013530433 A JP2013530433 A JP 2013530433A JP 2013530433 A JP2013530433 A JP 2013530433A JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5
Authority
JP
Japan
Prior art keywords
peptide
seq
chimeric
peptide according
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013530433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505655A (ja
JP6073230B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/053764 external-priority patent/WO2012050921A2/en
Publication of JP2014505655A publication Critical patent/JP2014505655A/ja
Publication of JP2014505655A5 publication Critical patent/JP2014505655A5/ja
Application granted granted Critical
Publication of JP6073230B2 publication Critical patent/JP6073230B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013530433A 2010-09-28 2011-09-28 Nd2ペプチドおよび神経疾患の治療方法 Expired - Fee Related JP6073230B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38743910P 2010-09-28 2010-09-28
US61/387,439 2010-09-28
PCT/US2011/053764 WO2012050921A2 (en) 2010-09-28 2011-09-28 Nd2 peptides and methods of treating neurological disease

Publications (3)

Publication Number Publication Date
JP2014505655A JP2014505655A (ja) 2014-03-06
JP2014505655A5 true JP2014505655A5 (https=) 2016-02-25
JP6073230B2 JP6073230B2 (ja) 2017-02-01

Family

ID=45938878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530433A Expired - Fee Related JP6073230B2 (ja) 2010-09-28 2011-09-28 Nd2ペプチドおよび神経疾患の治療方法

Country Status (15)

Country Link
US (1) US9073976B2 (https=)
EP (1) EP2621945B1 (https=)
JP (1) JP6073230B2 (https=)
KR (1) KR101893473B1 (https=)
CN (1) CN103282379B (https=)
AU (1) AU2011314074B2 (https=)
BR (1) BR112013007557A2 (https=)
CA (1) CA2812948C (https=)
DK (1) DK2621945T3 (https=)
IL (1) IL225464B (https=)
MX (1) MX343366B (https=)
RU (1) RU2607033C2 (https=)
SG (1) SG189104A1 (https=)
UA (1) UA114592C2 (https=)
WO (1) WO2012050921A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015181756A1 (en) * 2014-05-28 2015-12-03 Nono Inc. Chloride salt of tat-nr2b9c
WO2017147298A1 (en) * 2016-02-23 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Peptide-based methods for treating neurological injury
KR102253900B1 (ko) * 2016-04-27 2021-05-18 바이오셀즈(베이징) 바이오테크 코., 엘티디. 흥분성 신경독성 관련 손상 치료용 펩타이드
GB201620611D0 (en) 2016-12-05 2017-01-18 Univ Of Lancaster Treatment of neurological diseases
CN111499717B (zh) * 2020-04-10 2020-11-24 南京市儿童医院 一种脑源肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512673A (ja) * 1997-08-12 2001-08-28 ブリストル−マイヤーズ スクイブ カンパニー Kcnqカリウムチャンネルおよびそれの活性調節方法
AU3885300A (en) 1999-03-19 2000-10-09 Human Genome Sciences, Inc. 50 human secreted proteins
BRPI0116728B1 (pt) * 2001-01-05 2018-10-30 Pfizer Inc. anticorpos para receptor de fator de crescimento i semelhante à insulina
MXPA05001804A (es) * 2002-08-14 2005-05-27 Vertex Pharma Inhibidores de proteinas cinasas y usos de los mismos.
US20060030534A1 (en) * 2002-09-04 2006-02-09 Gabriele Dorn Treatment of neurological disorders by dsrna administration
US7425540B2 (en) * 2004-03-30 2008-09-16 The Hospital For Sick Children Method for modification of NMDA receptors through inhibition of Src
US8003609B2 (en) 2004-03-30 2011-08-23 The Hospital For Sick Children Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
EP1912680B1 (en) * 2005-06-15 2014-11-26 The Ohio State University Research Foundation Her-2 peptides
ES2446292T3 (es) * 2007-03-02 2014-03-07 Nono Inc. Tratamiento del accidente cerebrovascular y otras enfermedades sin inhibir los canales de calcio de tipo N

Similar Documents

Publication Publication Date Title
EP3371207B1 (en) Nucleic acids, peptides and methods
ES2643641T3 (es) Polipéptidos de hormona del crecimiento y métodos de producción y uso de los mismos
JP2014505655A5 (https=)
EP2594581A3 (en) Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens
Rai Peptide and protein mimetics by retro and retroinverso analogs
JP2011526886A5 (https=)
WO2010111617A4 (en) Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2010537638A5 (https=)
JP2014501510A5 (https=)
JP2013518115A5 (https=)
ES2694418T3 (es) Análogos de insulina de cadena sencilla de acción prolongada
JP2010024250A (ja) 生物学的エフェクターの細胞内送達
JP2012082206A5 (https=)
JP2011501652A5 (https=)
IN2012DN03368A (https=)
JP2014506450A5 (https=)
JP2018538356A5 (https=)
JP2009529509A5 (https=)
CN117279618A (zh) 用于靶标分子的选择性耗竭的组合物和方法
JP2011509093A5 (https=)
GB2528436A (en) Treatment of neurological diseases
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
Zhang et al. Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues
MX381786B (es) Gen insecticida variante axmi115 y métodos para utilizarlo.
WO2011048503A3 (en) Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof